organ testing

R&D

Researchers are beginning to imagine a future in which development pipelines are more predictive, more efficient, and ultimately more humane.

News

GSK has had a solid start to 2026, with revenues rising ahead of analyst expectations in the first full quarter under new CEO Luke Miels.

Sales & Marketing

As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.